Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the impact of ERT on LV diastolic function and flow in patients with Fabry's cardiomyopathy using diastolic stress echocardiography, LV vortex flow and CMR.


Clinical Trial Description

1. Objectives -The purpose of this study is to evaluate the impact of ERT on LV diastolic function and flow in patients with Fabry's cardiomyopathy using diastolic stress echocardiography, LV vortex flow and CMR. 2. Primary / Secondary Endpoint 1) Primary endpoint - Changes of peak exercise E/E' by diastolic stress echocardiography (RECAP-F STRESS trial) and LV vortex flow parameters (RECAP-F FLOW trial) at 1 year follow up. 2) Secondary endpoint - Changes of extracellular volume by CMR(T1 mapping) at 1 year follow up (RECAP-F trial) ② Evaluation of the degree of the resting LV diastolic function ③ Other echo-parameters; LV mass index at baseline, 1 year follow up, reduction of peak exercise E/E prime at 1 year follow up - Changes of quality of life using questionnaire ⑤ Change of peak VO2, exercise time, AT by diastolic stress echocardiography at 1 year follow up ⑥ Change in T1 baseline(myo, ms) & T1 baseline(blood, ms) T1 postcontrast(myo, ms) & T1 baseline(blood, ms) by CMR 3. Study Methods 1) Study Design : 28 patients with newly diagnosed genetically confirmed Anderson-Fabry's disease will undergo diastolic stress echocardiography, LV vortex flow analysis, and cardiac MRI before enzyme replacement therapy(ERT) (baseline study) and after 1 year of treatment with agalsidese beta at the dose of 1mg/kg (follow-up study). 2) Study procedures : Examinations as described below will be done before ERT and 1 year later ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02469181
Study type Observational
Source Yonsei University
Contact Geu Ru Hong, M.D., Ph.D.
Phone 82-2-2228-8443
Email grhong@yuhs.ac
Status Recruiting
Phase
Start date May 21, 2015
Completion date October 2024

See also
  Status Clinical Trial Phase
Completed NCT01178164 - Prevalence of Fabry's Disease in a Population of Patients With Chronic Pains N/A
Terminated NCT02582294 - Fabry's Disease and Pregnancy (PREFAB)
Recruiting NCT06019728 - A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme Phase 4
Completed NCT02798458 - Evaluation of the Gastrointestinal Manifestation of Fabry's Disease N/A
Completed NCT00001491 - Analysis of the Nervous System in Patients With Fabry's Disease N/A
Completed NCT02450604 - Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain N/A
Recruiting NCT04847713 - Early Detection and Follow-Up of Patients With Fabry's Disease